|Bid||86.16 x 800|
|Ask||86.20 x 800|
|Day's Range||86.15 - 87.25|
|52 Week Range||76.41 - 100.15|
|Beta (3Y Monthly)||0.70|
|PE Ratio (TTM)||54.19|
|Earnings Date||Feb 19, 2019|
|Forward Dividend & Yield||2.00 (2.28%)|
|1y Target Est||101.71|
The Food and Drug Administration sounded an alarm Thursday about certain drug-coated stents and balloons used to treat coronary and peripheral artery disease.
NEW YORK, NY / ACCESSWIRE / January 23, 2019 / U.S. markets declined on Tuesday, breaking a streak of four consecutive days in the green, on growing trade concerns. Stocks were pressured lower on reports ...
# Medtronic PLC ### NYSE:MDT View full report here! ## Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is extremely low for MDT with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MDT. ## Money flow ETF/Index ownership | Negative ETF activity is negative and may be weakening. The net inflows of $704 million over the last one-month into ETFs that hold MDT are among the lowest of the last year and appear to be slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to email@example.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Shares of Dublin-based Medtronic Plc fell 0.5% in premarket trade Tuesday morning after the company announced its paclitaxel-coated balloon for angioplasty did not show any significant difference in mortality compared to plain balloon angioplasty in patients with peripheral artery disease. Researchers followed 1,837 angioplasty patients over five years, but the resulting data did not show a statistically significant difference in the death rate between patients who received the drug-coated balloon and those who received plain balloon, the company said. There was also no correlation between drug dose and long-term survival and no significant difference in the dose of paclitaxel in patients who survived and those who did not. However, a smaller 100-patient study in Japan showed more positive results: Those who received the drug-coated balloon had a lower mortality rate than those who did not, the company said. Shares of Medtronic have fallen 4% in the year to date through Monday, while the S&P 500 has gained 6.5%.
Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency DUBLIN and LEIPZIG, Germany - January 22, 2019 - Medtronic plc (NYSE:MDT) today announced new data shared on the ...
came up in the fast-paced "Lightning Round" of Thursday night's Mad Money program. Jim Cramer's comment on MDT was:"This is a total winner." Let's check the charts and indicators before a long holiday weekend. In the daily bar chart of MDT, below, we can find bullish and bearish technical signals.
On CNBC's "Mad Money Lightning Round" , Jim Cramer said there was really no reason for a sell-off in Brink's Company (NYSE: BCO ). He thinks the quarter was great and he wants to buy the stock. ...
Jim Cramer shares his responses to callers' stock questions, including that of an automaker that recently lost its leader.
Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids DUBLIN - January 17, 2019 ...
Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Medtronic plc (NYSE:MDT) as an investment opportunity by taking the expected Read More...
Edwards Lifesciences and Boston Scientific stocks hit one-month highs Tuesday after the duo settled a patent battle related to transcatheter aortic heart-valve replacements.
Shares of medical technology company Medtronic PLC (NYSE: MDT ) were flirting with the $100 per share mark for parts of 2018, but have since come down to a level that should be taken advantage of by investors, ...